A strong case for third-party testing
2023
Fridtjof Lund-Johansen
A strategy to identify high-quality commercially available antibodies for research reveals extensive use of non-specific antibodies and offers solutions for future large-scale testing.
Показать больше [+] Меньше [-]Библиографическая информация
eLife
Том
12
ISSN
2050-084X
Издатель
eLife Sciences Publications Ltd
Другие темы
Polyclonal antibody; Antibody specificity; Antibody validation; Recombinant antibody; Antibody
Язык
Английский
2024-12-12
DOAJ
Поставщик данных
Эту запись предоставил Directory of Open Access Journals
If you notice any incorrect information relating to this record, please contact us at agris@fao.org agris@fao.org
